Structural and biochemical characterization establishes a detailed understanding of KEAP1-CUL3 complex assembly
Journal article
Adamson RJ. et al, (2023), Free Radical Biology and Medicine
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective.
Journal article
Ong HW. et al, (2023), ACS Chem Neurosci
Target 2035 – an update on private sector contributions
Journal article
Ackloo S. et al, (2023), RSC Medicinal Chemistry
Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP).
Journal article
Smilde BJ. et al, (2022), BMC musculoskeletal disorders, 23
Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation
Journal article
Chen Z. et al, (2022), Cell Death & Differentiation
Sequence and structural variations determining the recruitment of WNK kinases to the KLHL3 E3 ligase.
Journal article
Chen Z. et al, (2022), The Biochemical journal
Ubiquitin ligases: guardians of mammalian development
Journal article
Cruz Walma DA. et al, (2022), Nature Reviews Molecular Cell Biology
Target 2035-update on the quest for a probe for every protein
Journal article
Mueller S. et al, (2021), RSC MEDICINAL CHEMISTRY
Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe.
Journal article
Röhm S. et al, (2021), Journal of medicinal chemistry, 64, 13451 - 13474
Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
Journal article
Ventura F. et al, (2021), Biomedicines, 9, 213 - 213
ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex
Journal article
Williams E. et al, (2021), Biomedicines, 9, 129 - 129
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity
Journal article
Schröder M. et al, (2020), Journal of Medicinal Chemistry, 63, 10224 - 10234
Leveraging an Open Science Drug Discovery Model to Develop CNS Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma
Journal article
Smil D. et al, (2020), Journal of Medicinal Chemistry
Sequence and structural variations determining the recruitment of WNK kinases to the KLHL3 E3 ligase
Journal article
Chen Z. et al, (2020)
Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold.
Journal article
Suebsuwong C. et al, (2020), European journal of medicinal chemistry, 200
Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma.
Journal article
Ensan D. et al, (2020), Journal of medicinal chemistry, 63, 4978 - 4996
A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5
Journal article
Hanke T. et al, (2020), ACS Chemical Biology
Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas
Journal article
Fortin J. et al, (2020), Cancer Cell
Identification of a PGXPP degron motif in dishevelled and structural basis for its binding to the E3 ligase KLHL12
Journal article
Chen Z. et al, (2020)
Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency
Journal article
Hong Y. et al, (2020), Journal of Allergy and Clinical Immunology, 145, 701 - 705.e8